Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection

To assess the clinical effectiveness and safety of the combined Antiretroviral Treatment containing ABC relative to ABC-sparing cART. A subgroup comparison will be performed in studies comparing Antiretroviral Treatment containing ABC relative to TDF containing cART.

This is a protocol.

Share/Save